#1
| |||
| |||
Amgen Bite Technology |
#2
| |||
| |||
Re: amgen bite technology
I shifted to Thousand Oaks, CA and came to know about the Amgen Bite Technology which is related to Cancer Cells. Will you please provide me basic details about Cancer Cells Amgen Bite Technology and also provide complete address and contact details of Amgen Inc. Corporation?
|
#3
| |||
| |||
Re: amgen bite technology
BiTE® Antibodies: Designed to Bridge T Cells to Cancer Cells An Investigational Technology from Amgen Cytotoxic T-Lymphocytes (CTLs) have an innate ability to target tumor cells, and evidence supports a role for immunosurveillance in tumor targeting. By recognizing and binding to tumor cells, CTLs can lead to tumor cell lysis. Tumor cells can evade destruction by cytotoxic T cells Modification of tumor microenvironment by secretion of immunosuppressive cytokines such as TGF-β2 Modification of immune cell repertoire by stimulation of immunosuppressive response2,3 Generation of IDO2 Loss or mutation of MHC class I on tumor cells2 Interference with perforin/granzyme pathway4,5 Exploitation of immune-checkpoint proteins Increased CTLA-4 expression on T cells counteracts CD284 Increased PD-1 expression on T cells4 Inhibition of kinases involved in T cell activation5 Persistent PD-1 expression causing T cell exhaustive state5 Increased PD-L1 expression on tumor cell surface4 Contact: Corporate Headquarters Amgen Inc. One Amgen Center Drive Thousand Oaks, CA 91320-1799 Phone: +1 805-447-1000 Fax: +1 805-447-1010 |
|